Novo Nordisk | NVO - Ebit





Ebit Veränderung Datum
ANI Pharmaceuticals USD 39.84M 1.13M 2026-06
Aurora Cannabis CAD 7.12M 42.91M 2026-03
Bausch Health Companies USD 776M 287M 2026-06
Bristol-Myers Squibb USD 299M 3.26B 2026-06
Canopy Growth CAD -145.65M 132.99M 2026-03
Corcept Therapeutics USD 41.3M 90.9M 2026-06
Drreddys Laboratories INR 3.05B 13.32B 2026-03
Eli Lilly USD 12.46B 2.68B 2026-06
GlaxoSmithKline GBP 2.6B 312M 2026-06
Merck USD 840M 2.72B 2026-06
Nektar Therapeutics USD -38.26M 19.17M 2026-03
Novartis USD 4.73B 549M 2026-06
Novo Nordisk DKK 33.76B 25.86B 2026-06
Novo Nordisk DKK 5.25B 60.42B 2026-06
Pacira USD 9.96M 5.33M 2026-06
Perrigo USD 33.6M 50.8M 2026-03
Phibro Animal Health USD 54.99M 2.36M 2025-12
Prestige Brands USD 52.52M 22.97M 2026-06
Sanofi EUR 1.12B 811M 2026-06
Supernus Pharmaceuticals USD -21.04M 14.21M 2026-06
Zoetis USD 1.12B 279M 2026-06